within Pharmacolibrary.Drugs.ATC.R;

model R02AD01
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00015,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R02AD01</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Benzocaine is a local anesthetic commonly used as a topical pain reliever for conditions such as sore throat, minor burns, and insect bites. It is an ester-type anesthetic and is not generally used systemically. Benzocaine is available as over-the-counter products, such as lozenges, sprays, and creams. However, its use is limited due to risks including methemoglobinemia. Benzocaine is approved for topical use but not for parenteral or systemic use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters of benzocaine administered topically or orally have not been established in humans in published literature. Due to limited systemic absorption and lack of PK studies, typical compartmental pharmacokinetic parameters are not reported. The following are estimated parameters based on similar local anesthetics and physicochemical properties; specific human PK values are unavailable.</p><h4>References</h4><ol><li><p>Souza, AD, et al., &amp; de Paula, E (2024). Fresh Carrier for an Old Topical Local Anesthetic: Benzocaine in Nanostructured Lipid Carriers. <i>ACS biomaterials science &amp; engineering</i> 10(8) 4958–4969. DOI:<a href=\"https://doi.org/10.1021/acsbiomaterials.4c00585\">10.1021/acsbiomaterials.4c00585</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39074333/\">https://pubmed.ncbi.nlm.nih.gov/39074333</a></p></li><li><p>Bronaugh, RL, et al., &amp; Kraeling, ME (1994). Influence of metabolism in skin on dosimetry after topical exposure. <i>Environmental health perspectives</i> 102 Suppl 11(Suppl 11) 71–74. DOI:<a href=\"https://doi.org/10.1289/ehp.94102s1171\">10.1289/ehp.94102s1171</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7737045/\">https://pubmed.ncbi.nlm.nih.gov/7737045</a></p></li><li><p>Campos, EVR, et al., &amp; de Araujo, DR (2022). Using Chitosan-Coated Polymeric Nanoparticles-Thermosensitive Hydrogels in association with Limonene as Skin Drug Delivery Strategy. <i>BioMed research international</i> 2022 9165443–None. DOI:<a href=\"https://doi.org/10.1155/2022/9165443\">10.1155/2022/9165443</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35434138/\">https://pubmed.ncbi.nlm.nih.gov/35434138</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R02AD01;
